← All organizations
Highest phase reached
Phase 4
First clinical trial
Aug 6, 2016Last known activity
Mar 1, 2019
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (8)
- NCT04013659Reponsible party - principal investigatorPhase 1Mar 1, 2019
- NCT04013659Lead sponsorPhase 1Mar 1, 2019
- NCT03812965Reponsible party - principal investigatorPhase 2Aug 1, 2018
- NCT03812965Study chairPhase 2Aug 1, 2018
- NCT03812965Lead sponsorPhase 2Aug 1, 2018
- NCT03812965Overall official - principal investigatorPhase 2Aug 1, 2018
- NCT03044938Reponsible party - principal investigatorPhase 4Aug 6, 2016
- NCT03044938Lead sponsorPhase 4Aug 6, 2016
Details
- Last known activity
- Mar 1, 2019